HUE049186T2 - Emészthetetlen kapszulák folyadékabszorbeáló anyagok szállításához - Google Patents
Emészthetetlen kapszulák folyadékabszorbeáló anyagok szállításáhozInfo
- Publication number
- HUE049186T2 HUE049186T2 HUE12819632A HUE12819632A HUE049186T2 HU E049186 T2 HUE049186 T2 HU E049186T2 HU E12819632 A HUE12819632 A HU E12819632A HU E12819632 A HUE12819632 A HU E12819632A HU E049186 T2 HUE049186 T2 HU E049186T2
- Authority
- HU
- Hungary
- Prior art keywords
- delivery
- absorbing materials
- fluid absorbing
- digestible capsules
- digestible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161513923P | 2011-08-01 | 2011-08-01 | |
| US201161523787P | 2011-08-15 | 2011-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE049186T2 true HUE049186T2 (hu) | 2020-09-28 |
Family
ID=47629668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE12819632A HUE049186T2 (hu) | 2011-08-01 | 2012-08-01 | Emészthetetlen kapszulák folyadékabszorbeáló anyagok szállításához |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20150216808A1 (hu) |
| EP (1) | EP2739270B1 (hu) |
| JP (2) | JP2014521689A (hu) |
| CA (1) | CA2842802C (hu) |
| CY (1) | CY1123430T1 (hu) |
| DK (1) | DK2739270T3 (hu) |
| ES (1) | ES2782523T3 (hu) |
| HR (1) | HRP20200463T1 (hu) |
| HU (1) | HUE049186T2 (hu) |
| LT (1) | LT2739270T (hu) |
| PL (1) | PL2739270T3 (hu) |
| PT (1) | PT2739270T (hu) |
| RS (1) | RS60294B1 (hu) |
| SI (1) | SI2739270T1 (hu) |
| WO (1) | WO2013019891A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11484579B2 (en) * | 2017-11-29 | 2022-11-01 | Edgar L Hull | Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE169293C1 (hu) | 1958-03-13 | 1959-11-10 | ||
| US3042667A (en) | 1959-03-10 | 1962-07-03 | Pharmacia Ab | Process for producing dextran derivatives and products resulting therefrom |
| SE319903B (hu) | 1964-01-31 | 1970-01-26 | Pharmacia Ab | |
| US3300474A (en) | 1964-02-12 | 1967-01-24 | Pharmacia Ab | Sucrose ether copolymerizates |
| US3518340A (en) | 1968-04-15 | 1970-06-30 | Dow Corning | Method of forming silicone rubber drug carriers |
| GB1348642A (en) * | 1970-10-15 | 1974-03-20 | Howard A N | Hypocholesterolaemic compositions |
| US4470975A (en) * | 1977-10-21 | 1984-09-11 | The Johns Hopkins University | Method and composition for the elimination of water from an animal body |
| JPS5858146A (ja) * | 1981-10-05 | 1983-04-06 | Tanabe Seiyaku Co Ltd | 速放性マイクロカプセル |
| US4663148A (en) * | 1984-03-21 | 1987-05-05 | Alza Corporation | Dispenser comprising telescopically engaging members |
| GB2155889B (en) * | 1984-03-21 | 1988-03-02 | Alza Corp | Dispenser-capsule |
| AU629915B2 (en) * | 1989-02-16 | 1992-10-15 | British Technology Group Limited | Dispensing device |
| GB8903564D0 (en) * | 1989-02-16 | 1989-04-05 | Rashid Abdul | Drug dispensing device |
| US5264223A (en) * | 1990-03-29 | 1993-11-23 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
| US5169638A (en) * | 1991-10-23 | 1992-12-08 | E. R. Squibb & Sons, Inc. | Buoyant controlled release powder formulation |
| GB9223172D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Capsule construction |
| JP3238350B2 (ja) | 1997-05-27 | 2001-12-10 | 三粧化研株式会社 | 可食性パール状カプセルおよびその製造法 |
| WO2002040039A2 (en) * | 2000-11-20 | 2002-05-23 | Dow Global Technologies Inc. | In vivo use of water absorbent polymers |
| WO2002062356A2 (en) * | 2001-02-06 | 2002-08-15 | Ash Medical Systems, Inc. | Monovalent-selective cation exchangers as oral sorbent therapy |
| NO20021592D0 (no) | 2002-04-04 | 2002-04-04 | Fmc Biopolymer As | Polysakkaridkapsler og fremgangsmåte ved fremstilling derav |
| MXPA05002728A (es) * | 2002-09-13 | 2005-07-25 | Cydex Inc | Capsulas que contienen composiciones de relleno acuoso estabilizadas con ciclodextrina derivada. |
| DE50305197D1 (de) * | 2003-12-04 | 2006-11-09 | Cognis France Sas | Zubereitung für die orale und/oder topische Anwendung (I) |
| US20070141137A1 (en) | 2004-03-04 | 2007-06-21 | Naoki Nagahara | Stable capsule preparation |
| US9233075B2 (en) * | 2005-08-09 | 2016-01-12 | Metacure Limited | Satiety |
| JP5372525B2 (ja) | 2006-03-03 | 2013-12-18 | エフ エム シー コーポレーション | カプセルの製造方法および該製造方法により製造されるカプセル |
| CA2647487C (en) * | 2006-03-29 | 2014-10-21 | Electronic Dietary Foods Inc. | Ingestible implement for weight control |
| US20080268045A1 (en) * | 2006-11-09 | 2008-10-30 | Proprius Pharmaceuticals, Inc. | Sustained release methotrexate formulations and methods of use thereof |
| GB0625180D0 (en) * | 2006-12-15 | 2007-01-24 | Mw Encap Ltd | Improved hard shell capsules |
| CA2697803A1 (en) * | 2007-08-29 | 2009-03-05 | Sorbent Therapeutics, Inc. | Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
| WO2009049105A2 (en) * | 2007-10-09 | 2009-04-16 | Gelesis, Inc. | Methods for inducing satiation |
| WO2010065784A2 (en) * | 2008-12-03 | 2010-06-10 | Jakk Group, Inc. | Methods, devices, and compositions for dermal filling |
| US20100291201A1 (en) * | 2009-05-14 | 2010-11-18 | Cerovene, Inc. | Coated pharmaceutical capsule dosage form |
| US8101203B2 (en) * | 2010-01-14 | 2012-01-24 | Karl Wei Cao | Hard capsule composition and method of use |
-
2012
- 2012-08-01 WO PCT/US2012/049209 patent/WO2013019891A1/en active Application Filing
- 2012-08-01 PL PL12819632T patent/PL2739270T3/pl unknown
- 2012-08-01 US US14/236,828 patent/US20150216808A1/en not_active Abandoned
- 2012-08-01 HU HUE12819632A patent/HUE049186T2/hu unknown
- 2012-08-01 DK DK12819632.6T patent/DK2739270T3/da active
- 2012-08-01 ES ES12819632T patent/ES2782523T3/es active Active
- 2012-08-01 LT LTEP12819632.6T patent/LT2739270T/lt unknown
- 2012-08-01 CA CA2842802A patent/CA2842802C/en active Active
- 2012-08-01 PT PT128196326T patent/PT2739270T/pt unknown
- 2012-08-01 JP JP2014524055A patent/JP2014521689A/ja active Pending
- 2012-08-01 EP EP12819632.6A patent/EP2739270B1/en active Active
- 2012-08-01 RS RS20200340A patent/RS60294B1/sr unknown
- 2012-08-01 SI SI201231751T patent/SI2739270T1/sl unknown
-
2017
- 2017-01-04 JP JP2017000144A patent/JP6446071B2/ja active Active
-
2020
- 2020-03-20 HR HRP20200463TT patent/HRP20200463T1/hr unknown
- 2020-04-02 CY CY20201100320T patent/CY1123430T1/el unknown
-
2021
- 2021-07-02 US US17/366,863 patent/US20210330595A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK2739270T3 (da) | 2020-04-06 |
| ES2782523T3 (es) | 2020-09-15 |
| US20210330595A1 (en) | 2021-10-28 |
| EP2739270B1 (en) | 2020-01-01 |
| CA2842802C (en) | 2020-03-10 |
| JP2017081973A (ja) | 2017-05-18 |
| WO2013019891A1 (en) | 2013-02-07 |
| JP6446071B2 (ja) | 2018-12-26 |
| PT2739270T (pt) | 2020-04-02 |
| RS60294B1 (sr) | 2020-07-31 |
| LT2739270T (lt) | 2020-07-10 |
| JP2014521689A (ja) | 2014-08-28 |
| PL2739270T3 (pl) | 2020-10-05 |
| US20150216808A1 (en) | 2015-08-06 |
| EP2739270A4 (en) | 2015-01-14 |
| SI2739270T1 (sl) | 2020-10-30 |
| CY1123430T1 (el) | 2021-12-31 |
| EP2739270A1 (en) | 2014-06-11 |
| CA2842802A1 (en) | 2013-02-07 |
| HRP20200463T1 (hr) | 2020-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2758965T (lt) | Dviejų skysčių reaktorius | |
| SI2776416T1 (sl) | Farmacevtske spojine | |
| HK1200726A1 (zh) | 抗糖尿病化合物 | |
| AU341094S (en) | Capsule for infusion | |
| ZA201400901B (en) | Supramolecular capsules | |
| EP2746362A4 (en) | SCINTILLATOR | |
| EP2864361A4 (en) | DOSAGE REGIME OF FUSION COMPOUNDS | |
| HK1201534A1 (en) | Pharmaceutical compounds | |
| GB201119799D0 (en) | Pharmaceutical compounds | |
| GB2525835B (en) | Pharmaceutical agent | |
| SI2768485T1 (sl) | Farmacevtska nanosuspenzija | |
| EP2731610A4 (en) | PHARMACEUTICAL COMBINATION | |
| GB201118876D0 (en) | Pharmaceutical compounds | |
| GB201113163D0 (en) | Pharmaceutical compounds | |
| EP2687212A4 (en) | DRUG AGENT | |
| RS60294B1 (sr) | Nesvarljive kapsule za isporuku materijala koji apsorbuju tečnosti | |
| ZA201400726B (en) | Anticancer agent | |
| IL229060A0 (en) | Pharmaceutical preparations containing paclitaxel orotate | |
| GB201118839D0 (en) | Passive fluid detector | |
| GB201118875D0 (en) | Pharmaceutical compounds | |
| GB201118874D0 (en) | Pharmaceutical compounds | |
| GB201117359D0 (en) | Pharmaceutical compounds | |
| GB201105026D0 (en) | Pharmaceutical compounds | |
| GB201108234D0 (en) | Pharmaceutical agent | |
| GB201112893D0 (en) | Supramolecular Capsules |